Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9

Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9

The role of Neurochondrin (NCDN) in humans is not well understood. Mice with a conditional Ncdn knock-out show epileptic seizures, depressive-like behaviours and impaired spatial learning. Using CRISPR/Cas9, we generated a Neurochondrin deficient human iPSC line KICRi002-A-3 carrying a homozygous 75...

Full description

Bibliographic Details
Main Authors:	Ambrin Fatima, Jens Schuster, Talia Akram, Maria Sobol, Jan Hoeber, Niklas Dahl
Format:	Article
Language:	English
Published:	Elsevier 2020-04-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506120300623

Similar Items

Incontinentia pigmenti: Generation of an IKBKG deficient human iPSC line (KICRi002-A-1) on a 46,XY background using CRISPR/Cas9
by: Ambrin Fatima, et al.
Published: (2020-04-01)

Generation of two human iPSC lines (UUIGPi013-A and UUIPGi014-A) from cases with Down syndrome and full trisomy for chromosome 21 (T21)
by: Jens Schuster, et al.
Published: (2020-12-01)

Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations
by: Jens Schuster, et al.
Published: (2019-08-01)

Generation of human induced pluripotent stem cell (iPSC) lines (UUMCBi001-A, UUMCBi002-A) from two healthy donors
by: Svitlana Vasylovska, et al.
Published: (2021-01-01)

Generation of human induced pluripotent stem cell (iPSC) lines from three patients with von Hippel-Lindau syndrome carrying distinct VHL gene mutations
by: Jens Schuster, et al.
Published: (2019-07-01)

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for the STUB1 locus
by: Stefanie Schuster, et al.
Published: (2019-01-01)

Establishment of a GFP::LMNB1 knockin cell line (CSUi002-A-1) from a dystonia patient-specific iPSC by CRISPR/Cas9 editing
by: Yu Tang, et al.
Published: (2021-08-01)

Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing
by: S. Merkert, et al.
Published: (2021-01-01)

The use of the CRISPR-Cas9 system and iPSC-derived neurons with a SNCA mutation to model neurodegeneration
by: Mosaku, Olukunbi Eniola
Published: (2018)

Generation of induced pluripotent stem cell (iPSC) lines carrying a heterozygous (UKWMPi002-A-1) and null mutant knockout (UKWMPi002-A-2) of Cadherin 13 associated with neurodevelopmental disorders using CRISPR/Cas9
by: Maria Rosaria Vitale, et al.
Published: (2021-03-01)

Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment
by: Jens Schuster, et al.
Published: (2019-12-01)

Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages
by: Elena Navarro-Guerrero, et al.
Published: (2021-02-01)

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for PTCH1 gene
by: Bailing Zu, et al.
Published: (2021-10-01)

Generation and characterization of an endogenously tagged SPG11-human iPSC line by CRISPR/Cas9 mediated knock-in
by: Laura Krumm, et al.
Published: (2021-10-01)

Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing
by: Robert J. Barndt, et al.
Published: (2021-10-01)

Reversal of the Inflammatory Responses in Fabry Patient iPSC-Derived Cardiovascular Endothelial Cells by CRISPR/Cas9-Corrected Mutation
by: Hui-Yung Song, et al.
Published: (2021-02-01)

Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C
by: K.R. Valetdinova, et al.
Published: (2020-10-01)

Generation of integration free human iPSC line SORMi002-A from neonatal foreskin fibroblasts
by: Akshatha Shivaraj, et al.
Published: (2019-10-01)

Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency
by: Julio Castaño, et al.
Published: (2021-08-01)

Generation of gene-corrected iPSC line, KIOMi002-A, from Parkinson's disease patient iPSC with LRRK2 G2019S mutation using BAC-based homologous recombination
by: Seo-Young Lee, et al.
Published: (2019-12-01)

Generation of hemophilia B model hepatocyte derived from human iPSC via CRISPR/Cas9 mediated genome editing
by: Kwak, Peter
Published: (2018)

Derivation of iPSC lines from two idiopathic ASD patients (OFi001-A, OFi002-A)
by: Hao Guo, et al.
Published: (2021-10-01)

Generation of the CRISPR/Cas9-mediated KIF1C knock-out human iPSC line HIHRSi003-A-1
by: Maike Nagel, et al.
Published: (2020-12-01)

Generation of a heterozygous FLNC mutation-carrying human iPSC line, USFi002-A, for modeling dilated cardiomyopathy
by: Mariana A. Argenziano, et al.
Published: (2021-05-01)

Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation
by: Melissa Conti Mazza, et al.
Published: (2021-08-01)

The CIRM iPSC repository
by: Stephen S. Lin, et al.
Published: (2020-04-01)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)
by: Tadaaki Hanatani, et al.
Published: (2021-01-01)

CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A
by: Louise H.W. Kung, et al.
Published: (2020-10-01)

CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A
by: Kung, Louise H.W, et al.
Published: (2022)

CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A
by: Kung, Louise HW, et al.
Published: (2022)

CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2 N141I neurons
by: Maitane Ortiz-Virumbrales, et al.
Published: (2017-10-01)

Generation of a laminopathies-specific iPSC line EHTJUi005-A-3 with homozygous knockout of the LMNA gene by CRISPR/Cas9 technology
by: Ji-Zhen Lu, et al.
Published: (2021-10-01)

Induced pluripotent stem cell (iPSC) line (HEBHMUi002-A) from a healthy female individual and neural differentiation
by: Jun Ma, et al.
Published: (2020-01-01)

Generation and characterization of an iPSC line (SHCMDLi001-A) from a 12-year-old Chinese Han patient with TRAF7 syndrome and of an iPSC line (SHCMDLi002-A) from a control individual
by: Xiaozhen Song, et al.
Published: (2021-05-01)

Effective restoration of dystrophin expression in iPSC Mdx-derived muscle progenitor cells using the CRISPR/Cas9 system and homology-directed repair technology
by: Yue Jin, et al.
Published: (2020-01-01)

Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing
by: Yudha Nur Patria, et al.
Published: (2020-01-01)

CRISPR/Cas9 mediated generation of a iPSC line EHTJUi005-A-1 with homozygous knockout of the SUV39H1 gene
by: Zhi-Bin Qiao, et al.
Published: (2021-10-01)

iPSC for modeling neurodegenerative disorders
by: Valeria Valadez-Barba, et al.
Published: (2020-12-01)

Maturing iPSC-Derived Cardiomyocytes
by: Bor Luen Tang
Published: (2020-01-01)

iPSC Bioprinting: Where are We at?
by: Sara Romanazzo, et al.
Published: (2019-08-01)